Feature Robustness and Diagnostic Capabilities of Convolutional Neural Networks Against Radiomics Features in Computed Tomography Imaging.

Materials and Methods: Imaging phantoms were scanned twice on 3 computed tomography scanners from 2 different manufactures with varying tube voltages and currents. Phantoms were segmented, and features were extracted using PyRadiomics and a pretrained CNN. After standardization the concordance correlation coefficient (CCC), mean feature variance, feature range, and the coefficient of variant were calculated to assess feature robustness. In addition, the cosine similarity was calculated for the vectorized activation maps for an exemplary phantom. For the in vivo comparison, the radiomics and CNN features of 30 patients with hepatocellular carcinoma (HCC) and 30 patients with hepatic colon carcinoma metastasis were compared.
Results: In total, 851 radiomics features and 256 CNN features were extracted for each phantom. For all phantoms, the global CCC of the CNN features was above 98%, whereas the highest CCC for the radiomics features was 36%. The mean feature variance and feature range was significantly lower for the CNN features. Using a coefficient of variant ≤0.2 as a threshold to define robust features and averaging across all phantoms 346 of 851 (41%) radiomics features and 196 of 256 (77%) CNN features were found to be robust. The cosine similarity was greater than 0.98 for all scanner and parameter variations. In the retrospective analysis, 122 of the 256 CNN (49%) features showed significant differences between HCC and hepatic colon metastasis.
Discussion: Convolutional neural network features were more stable compared with radiomics features against technical variations. Moreover, the possibility of tumor entity differentiation based on CNN features was shown. Combined with visualization methods, CNN features are expected to increase reproducibility of quantitative image representations. Further studies are warranted to investigate the impact of feature stability on radiological image-based prediction of clinical outcomes.
Competing Interests: Conflicts of interest and sources of funding: none declared.
(Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)